Fredun Pharmaceuticals Ltd — Important, 10-11-2025: Company Update

Fredun Pharmaceuticals reported strong financial results for the half-year, with EBITDA growing by 61% to ₹39.33 Cr and Net Profit surging 96.33% to ₹16.50 Cr. Total income increased by 42.43% to ₹265.15 Cr. The company is expanding its Palghar manufacturing facility and making strategic moves in pet healthcare, including the successful launch of 'Snacky Jain' and acquisitions of Wagr.ai and One Pet Stop. To support growth, a preferential issue of equity shares and convertible warrants is underway, and a 7% final dividend was declared.